Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

NCT06210854 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

HPV Infection

Interventions

BIOLOGICAL: pBI-11 (3 doses)
BIOLOGICAL: pBI-11 (1 dose)
BIOLOGICAL: Placebo (2 doses)

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]
[object Object]